Peter Lemaire

Head of Analytical Science & Technology & Analytical Chemistry- Gene Therapy at PTC Therapeutics, Inc.

Speaker

Peter is Head of Analytical Science and Technology and Analytical Chemistry at PTC Therapeutics. He has 17 years of analytical experience in industry (BMS, Merck and PTC) enabling CMC of clinical and commercial drugs in multiple modalities (small molecules, antibodies, fusion proteins, antibody-drug-conjugates, combination biologics and AAVs). Prior, Peter spent 12 years in academia over 4 degrees (BS Biochemistry and MS Pharmaceutical Analysis and QC at University of Science & Technology, Ghana; MS Biotechnology at University of the Witwatersrand, South Africa; and PhD Biochemistry at University of Connecticut, U.S.A) while providing consultation to companies.